HsuYPHsuCWBaiCHChengSWChenC. Medical treatment for epistaxis in hereditary hemorrhagic telangiectasia: a meta-analysis [published online September11, 2018]. Otolaryngol Head Neck Surg. doi:10.1177/0194599818797316
2.
KritharisAAl-SamkariHKuterDJ.Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective. Haematologica. 2018;103:1433-1443.
3.
GuilhemAFargetonAESimonACet al. Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): a retrospective study of 46 patients. PLoS One. 2017;12:e0188943.
4.
IyerVNApalaDRPannuBSet al. Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia–related epistaxis and gastrointestinal bleeding. Mayo Clin Proc. 2018;93:155-166.
5.
Al-SamkariHKritharisARodriguez-LopezJMKuterDJ. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia [published online September6, 2018]. J Intern Med. doi:10.1111/joim.12832
